SCHEMBL503693

SCHEMBL503693

Cc1ccc(C)c(P(c2cc(C)ccc2C)c2cc(C)ccc2C)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.46
ALDH1A1 P00352 3/20 0.46
CYP2A6 P11509 4/20 0.41
CYP1A2 P05177 4/20 0.41
TP53 P04637 2/20 0.40
TAAR1 Q96RJ0 1/20 0.38
ACHE P22303 3/20 0.37
GAA P10253 3/20 0.37
HSD17B10 Q99714 2/20 0.37
RAPGEF4 Q8WZA2 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
CYP3A4 P08684 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TRPA1 O75762 1/20 0.36
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29409676 1.00 TDP1 (0.46) TDP1ALDH1A1CYP2A6CYP1A2TP53
SCHEMBL8925309 0.97 TDP1 (0.44) TDP1ALDH1A1CYP2A6CYP1A2TP53
SCHEMBL12592439 0.82 TDP1 (0.44) TDP1ALDH1A1CYP2A6ACHEGAA
SCHEMBL10796893 0.82 TDP1 (0.44) TDP1ALDH1A1CYP2A6ACHEKDM4E
SCHEMBL11308895 0.81 TDP1 (0.44) TDP1ALDH1A1CYP2A6CYP1A2TP53
SCHEMBL11601299 0.79 TDP1 (0.42) TDP1ALDH1A1CYP2A6CYP1A2TP53
SCHEMBL30029175 0.79 TDP1 (0.42) TDP1ALDH1A1CYP2A6CYP1A2TP53
SCHEMBL10974172 0.79 ALDH1A1 (0.42) TDP1ALDH1A1CYP2A6CYP1A2TP53
SCHEMBL7531460 0.79 TDP1 (0.42) TDP1ALDH1A1CYP2A6CYP1A2TP53
SCHEMBL28339874 0.79 TDP1 (0.42) TDP1ALDH1A1CYP2A6CYP1A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4667531-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF Teijin Limited (JP) 2025-12-24 EP claimed
WO-2024171845-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF 帝人株式会社 2024-08-22 WO claimed
CN-110359097-B Method for obtaining On-DNA aromatic hydrocarbon compound through Suzuki coupling reaction in construction of DNA coding compound library 上海药明康德新药开发有限公司 2022-09-20 CN claimed
CN-110331447-B Method for preparing On-DNA aryl alkyne compound in construction of DNA coding compound library 上海药明康德新药开发有限公司 2022-05-27 CN claimed
CN-110079867-B On-DNA wittig reaction method in DNA coding compound library and prepared On-DNA olefin compound 上海药明康德新药开发有限公司 2022-01-04 CN claimed
EP-4679461-A2 RESIN COMPOSITION AND PRODUCTION METHOD OF THE SAME AJINOMOTO CO., INC. (JP) 2026-01-14 EP disclosed
EP-4667531-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF Teijin Limited (JP) 2025-12-24 EP disclosed
EP-4631926-A1 METHOD FOR PRODUCING HOMO-COUPLING REACTION PRODUCT National University Corporation Hokkaido University (JP) 2025-10-15 EP disclosed
US-20250261553-A1 NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM AND ORGANIC SEMICONDUCTOR ELEMENT TOSOH CORPORATION (JP) 2025-08-14 US disclosed
EP-3521366-B1 CURABLE MODIFIED PETROLEUM RESIN, AND PREPARATION METHOD AND USE THEREOF KOLON INC (KR) 2025-07-30 EP disclosed
EP-4586285-A1 RESIN COMPOSITION AJINOMOTO CO., INC. (JP) 2025-07-16 EP disclosed
EP-3647333-B1 CURABLE PETROLEUM RESIN, PREPARATION METHOD THEREFOR, AND USE THEREOF KOLON INC (KR) 2025-06-18 EP disclosed
US-5583271-A Method for continuously producing alkadienols MITSUBISHI CHEMICAL CORPORATION (JP) 1996-12-10 US disclosed
US-5481049-A REACTING CONJUGATED DIENE AND WATER IN PRESENCE OF CARBON DIOXIDE, USING PALLADIUM COMPOUND AND A FREE PHOSPHINE AS CATALYSTS MITSUBISHI CHEMICAL CORPORATION (JP) 1996-01-02 US disclosed
US-5306835-A Bis(phosphine)palladium complex; catalyst for the dimerization hydration reaction of 1,3-butadiene and water to octadienols MITSUBISHI KASEI CORPORATION (JP) 1994-04-26 US disclosed
US-5283377-A Reacting butadiene/1,3-/ and water in the presence of a palladium compound, carbon dioxide and a triphenyl phsophine with electron donative substitutents MITSUBISHI KASEI CORPORATION (JP) 1994-02-01 US disclosed
EP-0000162-B1 Method for preparing aralkyl and alkyl phenol ethers BASF Aktiengesellschaft (DE) 1980-08-20 EP disclosed
US-4192949-A FROM CORRESPONDING PHENOLS BY ETHERIFICATION WITH DIALKYL CARBONATE IN TERTIARY AMINE OR PHOSPHINE BASF AKTIENGESELLSCHAFT (DE) 1980-03-11 US disclosed
EP-0000162-A1 Method for preparing aralkyl and alkyl phenol ethers BASF Aktiengesellschaft (DE) 1979-01-10 EP disclosed
US-3998872-A PREPARATION OF UNSATURATED CARBONYL COMPOUNDS UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250261553-A1 NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM AND ORGANIC SEMICONDUCTOR ELEMENT CD99, SOAT2, SOAT1 TDP1 1538/4885ALDH1A1 2113/4885CYP2A6 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.